AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tvardi Therapeutics, Inc. Director's Dealing 2021

Jan 25, 2021

9999_dirs_2021-01-25_23bbbef0-c8e7-4b01-982a-9467174e44c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cara Therapeutics, Inc. (CARA)
CIK: 0001346830
Period of Report: 2021-01-21

Reporting Person: Goncalves Joana (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-21	Common Stock	S	2000	$20.12	Disposed	28075	Direct

Footnotes

F1: This sale was made pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2019, and amended on August 19, 2020.